Diffuse dermal angiomatosis (DDA) is a rare skin condition in which tiny blood vessels proliferate throughout the deeper layer of the skin, typically in response to poor blood flow in the surrounding tissue. It shows up as painful, reddish-purple patches or plaques that can break down into open ulcers, most often on the legs of people with severe atherosclerosis or peripheral arterial disease. Because it mimics several other conditions and is genuinely uncommon, DDA is frequently misdiagnosed or discovered late, making awareness of its features and triggers especially useful for patients and clinicians alike.
What Diffuse Dermal Angiomatosis Looks Like
The skin changes in DDA tend to follow a recognizable pattern, though they can vary in severity. Early on, a person may notice a single reddish patch or a firm, discolored plaque surrounded by dusky skin. The affected area is typically tender or outright painful. As the condition progresses, the center of the plaque can ulcerate, leaving an open wound rimmed by purplish, sometimes necrotic tissue.1JAMA Dermatology. Diffuse Dermal Angiomatosis of the Breast The lesions may be solitary or multiple, and they can appear on both sides of the body.
The lower extremities, particularly the thighs, are the most common location. This makes sense given the condition’s strong association with blocked leg arteries. However, DDA also appears on the abdomen, trunk, shoulders, and breasts, depending on which area of the body is experiencing reduced blood flow.2PubMed Central. Diffuse Dermal Angiomatosis: A Clue to the Diagnosis of Atherosclerotic Vascular Disease Some patients develop a net-like, mottled discoloration of the skin (a livedoid pattern) around the plaques, which reflects the underlying vascular compromise.
The Underlying Mechanism
DDA is not a tumor or a cancer. It is a reactive process, meaning the body is responding to a stimulus rather than growing abnormally on its own. The current understanding is that when blood flow to a region of skin is chronically reduced, the resulting oxygen deprivation triggers the lining cells of blood vessels (endothelial cells) to multiply. This proliferation is driven by vascular endothelial growth factor, or VEGF, a signaling molecule the body releases when tissues are starved of oxygen.3PubMed Central. Persistent cutaneous abdominal ulcerations secondary to diffuse dermal angiomatosis: an underestimated sign for severe atherosclerosis The new vessels that form are fragile and poorly organized, which paradoxically makes the local circulation worse rather than better. Blood pools, small clots form, and the skin breaks down.
An important clinical implication of this mechanism is that DDA is reversible in principle. If you remove the trigger for the oxygen deprivation, the reactive blood-vessel growth can regress. This is why restoring blood flow through surgery or stenting has been the most consistently successful treatment, as we’ll see below.
Conditions That Set the Stage
Almost every reported case of DDA has occurred in someone with significant cardiovascular or metabolic disease. The condition is best understood as a skin-level signal of serious systemic vascular compromise. A literature review found that among 29 reported cases at the time, peripheral artery disease was the single most common association, present in about a third of cases.4PubMed Central. Diffuse Dermal Angiomatosis: A Clue to the Diagnosis of Atherosclerotic Vascular Disease Two early case reports that helped define the condition both involved patients with atherosclerosis severe enough to require bypass grafts.5PubMed. Diffuse dermal angiomatosis: a variant of reactive cutaneous angioendotheliomatosis
Beyond atherosclerosis and peripheral artery disease, several other conditions have been linked to DDA:
- End-stage renal disease: Kidney failure leads to metabolic changes that damage blood vessels throughout the body, creating the same kind of tissue oxygen deprivation that triggers DDA. In this setting, DDA can closely mimic calciphylaxis, a life-threatening condition involving calcium deposits in skin blood vessels.6PubMed Central. Diffuse dermal angiomatosis with clinical features simulating calciphylaxis in the setting of end-stage renal disease
- Calciphylaxis itself: Some patients develop DDA alongside or in proximity to calciphylaxis, and distinguishing the two requires a biopsy. Associated medical problems in these overlapping cases include hyperparathyroidism, blood clots, high blood pressure, and diabetes.7The American Journal of Dermatopathology. Diffuse Dermal Angiomatosis Associated With Calciphylaxis
- Hypercoagulability and trauma: Conditions that make blood more likely to clot, or physical injury to the affected area, can also serve as triggers.8PubMed. Diffuse dermal angiomatosis of the breast: clinicopathologic study of 5 patients
- Iatrogenic causes: At least one case has been traced to an arteriovenous fistula created during a medical procedure, which altered local blood flow enough to spark the reactive vascular growth.9PubMed. Diffuse dermal angiomatosis due to an iatrogenic arteriovenous fistula
Smoking and obesity show up repeatedly in case series, and both are powerful risk factors for the kinds of vascular disease that underlie DDA. In the largest single-institution series of DDA affecting the breast, roughly two-thirds of patients were obese and about a quarter were active smokers at the time of diagnosis.10PubMed Central. Diffuse dermal angiomatosis of the breast: a series of 22 cases from a single institution These are not independent causes of DDA, but they contribute to the vascular damage that sets the stage for it.
The Breast Variant
DDA of the breast (sometimes abbreviated DDAB) deserves special attention because it has a somewhat different patient profile and raises its own set of diagnostic concerns. Rather than occurring in patients with blocked leg arteries, DDAB tends to affect women with very large, pendulous breasts (macromastia). The weight and position of the breast tissue can compress the blood vessels supplying the overlying skin, creating a localized zone of oxygen deprivation similar to what peripheral artery disease does in the legs.
Clinically, DDAB presents as tender, reddish-to-purple plaques and purplish bumps on the breast skin. These lesions can progress to central ulceration with surrounding tissue death, creating painful, weeping wounds that understandably alarm patients and clinicians alike.11PubMed Central. Diffuse Dermal Angiomatosis of the Breast Because breast skin changes with ulceration can look like inflammatory breast cancer, biopsy is essential to distinguish DDA from a malignancy. In the 22-patient series mentioned earlier, obesity and tobacco use were strongly associated with DDAB, reinforcing the idea that compromised blood flow to the breast skin is the underlying driver.12PubMed Central. Diffuse dermal angiomatosis of the breast: a series of 22 cases from a single institution
Treating DDAB can be tricky. Revascularization, which works well when a specific blocked artery in the leg can be opened, is not always an option for the breast. Some reports describe success with breast reduction surgery, which removes the mechanical compression and restores blood flow to the skin. Other cases have been managed with steroids or anticoagulation, though the evidence for these approaches remains thin.
How DDA Is Diagnosed
DDA cannot be reliably diagnosed by appearance alone because the skin lesions overlap with a long list of other conditions. The gold standard is a skin biopsy, which reveals a distinctive microscopic pattern: a diffuse proliferation of benign endothelial cells scattered between the collagen fibers throughout the dermis.13PubMed. Diffuse dermal angiomatosis of the breast: clinicopathologic study of 5 patients The new vessels are not organized into neat lobules (which would point toward a different diagnosis) but instead spread out in a diffuse pattern. Small blood clots (fibrin thrombi) within some of the vessels are another common finding.14Clinical and Experimental Dermatology. Diffuse dermal angiomatosis associated with severe atherosclerosis: two cases and review of the literature
The biopsy findings help place DDA within a broader family of conditions grouped under the term “cutaneous reactive angiomatoses.” This umbrella category covers several related but distinct entities that all share a common thread of tissue oxygen deprivation triggering blood vessel growth. The three main subtypes are distinguished by the microscopic pattern: an intravascular pattern (cells growing inside existing vessels), a diffuse extravascular pattern (which is DDA), and a lobular extravascular pattern (sometimes called pseudo-Kaposi sarcoma).15PubMed Central. Diffuse Dermal Angiomatosis of the Breast: A Distinct Entity in the Spectrum of Cutaneous Reactive Angioproliferations Getting the subtype right matters because the associated conditions and treatment strategies can differ.
Beyond the biopsy, a thorough diagnostic workup for DDA should include an assessment of the patient’s vascular status. Since the condition is so closely linked to poor circulation, an ankle-brachial index, arterial duplex ultrasound, or angiography may uncover previously undiagnosed peripheral artery disease or atherosclerosis. In patients without obvious peripheral vascular disease, evaluating for renal failure, hypercoagulable states, and diabetes is reasonable.
Conditions That Mimic DDA
The reddish-purple plaques and ulceration of DDA can look strikingly similar to several other skin conditions, some of which are far more dangerous. Calciphylaxis, as noted above, is one of the closest mimics, especially in patients with kidney disease. Both conditions produce painful, purplish skin lesions that can ulcerate, and both occur in patients with severe systemic illness. A biopsy typically resolves the confusion: calciphylaxis shows calcium deposits in the walls of small blood vessels, while DDA shows endothelial cell proliferation without calcification.16PubMed Central. Diffuse dermal angiomatosis with clinical features simulating calciphylaxis in the setting of end-stage renal disease
Other conditions on the differential diagnosis include vasculitis (inflammation of blood vessel walls), various types of vasculopathy (blood vessel disease without frank inflammation), and in the breast specifically, inflammatory breast cancer. The presence of benign endothelial cells scattered through the dermis on biopsy, rather than malignant cells or vessel-wall inflammation, points toward DDA. Clinical context matters as well: a person with known severe peripheral artery disease who develops purplish, ulcerated plaques on the legs should have DDA high on the list of possibilities.
Treatment Approaches
Because DDA is driven by inadequate blood flow, the most effective treatment is restoring that blood flow. When the underlying problem is a blocked artery, revascularization through bypass surgery, endarterectomy, or stenting has produced the most consistent results. In one series, all patients who underwent revascularization saw their skin lesions and ulcers heal within about ten weeks.17European Journal of Vascular and Endovascular Surgery. Diffuse Dermal Angiomatosis Associated with Peripheral Vascular Atherosclerosis: A Case Report A more recent case report described a patient with DDA on the thigh whose disease progressed to toe ulcers before bilateral endarterectomy and aortoiliac stenting led to healing.18Journal of Vascular Surgery Cases, Innovations and Techniques. Diffuse dermal angiomatosis of the thigh as the presenting sign of critical limb ischemia
Revascularization isn’t always possible, however. Some patients have disease too diffuse for a single bypass or stent to fix. Others have comorbidities that make surgery high risk. In those cases, medical therapies have been tried with mixed results. Oral corticosteroids and anticoagulants have been reported as somewhat helpful in individual cases.19PubMed. Diffuse dermal angiomatosis of the breast: clinicopathologic study of 5 patients Isotretinoin, a vitamin A derivative better known for treating severe acne, produced improvement in at least one case of DDA affecting the breast.20PubMed. Diffuse dermal angiomatosis of the breast: response to isotretinoin But a review of 22 breast cases found that medical therapies other than revascularization generally showed little to no improvement overall.21PubMed Central. Diffuse dermal angiomatosis of the breast: a series of 22 cases from a single institution
The gap between revascularization outcomes and medical therapy outcomes underscores a frustrating reality: the patients who most need treatment are often the ones least able to undergo the procedure that works best. Many DDA patients are elderly, obese, diabetic, or dealing with kidney failure, all of which make surgical intervention riskier. Managing the condition in these patients often comes down to aggressive wound care, controlling cardiovascular risk factors (quitting smoking, managing blood pressure and blood sugar), and anticoagulation when blood clots are contributing to the problem.
Why DDA Gets Missed
Part of the reason DDA is underdiagnosed is sheer rarity. The condition was first described in the early 1990s, and published case counts remain in the dozens rather than the hundreds or thousands. A dermatologist or vascular surgeon might go an entire career without seeing a case, which makes pattern recognition difficult. The fact that DDA’s appearance overlaps with more common conditions means it often gets attributed to something else initially.
Another challenge is the patient population. People with severe atherosclerosis, poorly controlled diabetes, and end-stage renal disease frequently have chronic wounds and skin changes from multiple overlapping causes. A new purplish plaque on the leg of someone who already has stasis dermatitis, diabetic skin changes, and perhaps a previous amputation may not immediately trigger a biopsy. The literature suggests that DDA should be considered an underestimated marker of severe cardiovascular disease, particularly when standard wound treatments aren’t working.22PubMed Central. Persistent cutaneous abdominal ulcerations secondary to diffuse dermal angiomatosis: an underestimated sign for severe atherosclerosis A biopsy of a nonhealing, painful, purplish skin lesion in someone with known vascular disease can catch DDA before it leads to extensive ulceration.
DDA as a Cardiovascular Warning Sign
Perhaps the most clinically significant takeaway about DDA is what it tells you about the rest of the body. If the skin on someone’s leg or breast is so starved of oxygen that it starts growing new blood vessels reactively, the same kind of vascular compromise is likely happening elsewhere. Case reports consistently describe DDA patients as having extensive atherosclerosis affecting multiple vascular beds, not just the area where the skin lesion appears.23PubMed. Diffuse dermal angiomatosis associated with severe atherosclerosis: two cases and review of the literature One of the two patients in that report was a heavy smoker with severe, widespread peripheral artery disease.
For clinicians, a new diagnosis of DDA should prompt not just local wound management but a comprehensive cardiovascular evaluation. For patients, the presence of DDA is a tangible, visible reminder that the circulatory system is under significant stress. Addressing the modifiable risk factors, above all smoking cessation and tight control of blood pressure and blood sugar, becomes urgent rather than aspirational. The skin may be where the problem becomes visible, but DDA is ultimately a systemic disease showing up in a place you can see.